Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Literature DB >> 1003329

Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

J G Wagner.

Abstract

Mesh：

Substances：

Year: 1976 PMID： 1003329 DOI： 10.1007/bf01062831

Source DB: PubMed Journal: J Pharmacokinet Biopharm ISSN： 0090-466X

× No keyword cloud information.

7 in total

1. Do you need a pharmacokinetic model, and, if so, which one?

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1975-12

2. Linear pharmacokinetic models and vanishing exponential terms: implications in pharmacokinetics.

Authors: J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1976-10

3. Volume of distribution as a function of time.

Authors: S Niazi
Journal: J Pharm Sci Date: 1976-03 Impact factor: 3.534

4. CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates.

Authors: A J Sedman; J G Wagner
Journal: J Pharm Sci Date: 1976-07 Impact factor: 3.534

5. A safe method for rapidly achieving plasma concentration plateaus.

Authors: J G Wagner
Journal: Clin Pharmacol Ther Date: 1974-10 Impact factor: 6.875

6. Pharmacokinetics of orally administered acetaminophen in man.

Authors: K S Albert; A J Sedman; J G Wagner
Journal: J Pharmacokinet Biopharm Date: 1974-10

7. Blood levels of drug at the equilibrium state after multiple dosing.

Authors: J G Wagner; J I Northam; C D Alway; O S Carpenter
Journal: Nature Date: 1965-09-18 Impact factor: 49.962

7 in total

120 in total

1. The effect of dosing regimen on the pharmacokinetics of risedronate.

Authors: D Y Mitchell; M A Heise; K A Pallone; M E Clay; J D Nesbitt; D A Russell; C W Melson
Journal: Br J Clin Pharmacol Date: 1999-10 Impact factor: 4.335

2. Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer.

Authors: J A Benvenuto; R A Newman; G S Bignami; T J Raybould; M N Raber; L Esparza; R S Walters
Journal: Invest New Drugs Date: 1992-07 Impact factor: 3.850

3. Disposition of synethetic glucocorticoids. I. Pharmacokinetics of dexamethasone in healthy adults.

Authors: S E Tsuei; R G Moore; J J Ashley; W G McBride
Journal: J Pharmacokinet Biopharm Date: 1979-06

4. Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl.

Authors: Teijo I Saari; Kari Laine; Mikko Neuvonen; Pertti J Neuvonen; Klaus T Olkkola
Journal: Eur J Clin Pharmacol Date: 2007-11-07 Impact factor: 2.953

5. Effect of the CYP3A4 inhibitor erythromycin on the pharmacokinetics of lignocaine and its pharmacologically active metabolites in subjects with normal and impaired liver function.

Authors: Rocco Orlando; Pierpaolo Piccoli; Sara De Martin; Roberto Padrini; Pietro Palatini
Journal: Br J Clin Pharmacol Date: 2003-01 Impact factor: 4.335